Fasting plasma glucose as a screening test for gestational diabetes mellitus
- 12 September 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in Archiv für Gynäkologie
- Vol. 275 (2), 81-87
- https://doi.org/10.1007/s00404-006-0245-9
Abstract
Although debated, most preeminent expert panels recommend routine screening for gestational diabetes mellitus (GDM). Among the many tests that have been used and evaluated for the screening of GDM, the fasting plasma glucose (FPG) remains very appealing. It is easy to administer, well tolerated, inexpensive, reproducible and patient friendly. However attractive, the FPG has given varied results in different populations and its use as a screening test for GDM remains uncertain. This review will objectively assess the available studies to find the real value of FPG as a screening test for GDM.Keywords
This publication has 31 references indexed in Scilit:
- Gestational diabetes mellitus remains a riddle wrapped in a mystery inside an enigmaActa Obstetricia et Gynecologica Scandinavica, 2006
- Gestational diabetes: a reappraisal of HBA1c as a screening testActa Obstetricia et Gynecologica Scandinavica, 2005
- Gestational diabetes: dilemma caused by multiple international diagnostic criteriaDiabetic Medicine, 2005
- Gestational Diabetes Mellitus — Time to TreatNew England Journal of Medicine, 2005
- Screening for gestational diabetes; past, present and futureDiabetic Medicine, 2002
- Screening for gestational diabetes: a systematic review and economic evaluationHealth Technology Assessment, 2002
- ACOG Practice Bulletin No. 30: Gestational DiabetesObstetrics & Gynecology, 2001
- Screening for gestational diabetes: variation in guidelinesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2000
- Gestational diabetes mellitus ‐ management guidelines: The Australasian Diabetes in Pregnancy SocietyThe Medical Journal of Australia, 1998
- Screening for Gestational Diabetes MellitusNew England Journal of Medicine, 1997